{"nctId":"NCT00830167","briefTitle":"Randomized, Double-Blind, Placebo-Controlled Study Of Pregabalin In Patients With Fibromyalgia","startDateStruct":{"date":"2009-03"},"conditions":["Fibromyalgia"],"count":498,"armGroups":[{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]},{"label":"Pregabalin","type":"EXPERIMENTAL","interventionNames":["Drug: Pregabalin"]}],"interventions":[{"name":"Placebo","otherNames":[]},{"name":"Pregabalin","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* ACR criteria for fibromyalgia\n* A score of more or equal to 40 mm on the Pain VAS\n* An average score more or equal to 4 on 4 daily pain diaries\n\nExclusion Criteria:\n\n* Patients with other severe pain conditions\n* Patients with severe depression\n* Patients taking excluded medications\n* Patients with suicidality","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline for Numerical Rating Scale (NRS) Pain Scores at Endpoint-LOCF (Last Observation Carried Forward) Relative to Baseline","description":"Change from baseline in mean NRS-Pain scores at endpoint-LOCF. Daily pain scores were assessed on an 11-point numerical rating scale \\<(NRS)-Pain\\> ranging from 0 (no pain) to 10 (worst possible pain).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.03","spread":"0.12"},{"groupId":"OG001","value":"-1.48","spread":"0.12"}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants Who Was Categorized as \"Improved (Very Much Improved, Much Improved, or a Minimally Improved)\" According to the Patient Global Impressions of Change (PGIC)","description":"PGIC was defined as participant rated instrument to measure participant's change in overall status on a 7-point scale; range from 1 (very much improved) to 7 (very much worse). Change was defined as a score of 1 (very much improved), 2 (much improved), 3 (minimally improved), 4 (no change), 5 (minimally worse) , 6 (much worse) or 7 (very much worse) on the scale.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"62.1","spread":null},{"groupId":"OG001","value":"70.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Medical Outcomes Study (MOS) Sleep Scale at Endpoint- Sleep Disturbance","description":"MOS: participant-rated questionnaire to assess sleep quality and quantity. Consists of 9-item overall sleep problems index (length of time to fall asleep, how many hours of sleep each night during past 4 weeks); The MOS Sleep Disturbance subscales rated 1 (all the time) to 6 (none of the time). Scores are transformed (actual raw score minus lowest possible score) divided by possible raw score range multiplied by 100; total score range = 0 to 100. A higher score indicates greater intensity of sleep disturbance. Change = mean scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.13","spread":"1.31"},{"groupId":"OG001","value":"-17.62","spread":"1.31"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Medical Outcomes Study (MOS) Sleep Scale at Endpoint- Snoring","description":"MOS: participant-rated questionnaire to assess sleep quality and quantity. Consists of 9-item overall sleep problems index (length of time to fall asleep, how many hours of sleep each night during past 4 weeks); The MOS Snoring subscales rated 1 (all the time) to 6 (none of the time). Scores are transformed (actual raw score minus lowest possible score) divided by possible raw score range multiplied by 100; total score range = 0 to 100. A higher score indicates greater intensity of snoring. Change = mean scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.61","spread":"1.33"},{"groupId":"OG001","value":"3.37","spread":"1.33"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Medical Outcomes Study (MOS) Sleep Scale at Endpoint- Awaken Short of Breath or With a Headache","description":"MOS: participant-rated questionnaire to assess sleep quality and quantity. Consists of 9-item overall sleep problems index (length of time to fall asleep, how many hours of sleep each night during past 4 weeks); The MOS Awaken Short of Breath or With a Headache subscales rated 1 (all the time) to 6 (none of the time). Scores are transformed (actual raw score minus lowest possible score) divided by possible raw score range multiplied by 100; total score range = 0 to 100. A higher score indicates greater intensity of the symptom. Change = mean scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.02","spread":"1.36"},{"groupId":"OG001","value":"-8.01","spread":"1.36"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Medical Outcomes Study (MOS) Sleep Scale at Endpoint- Quantity of Sleep","description":"MOS: participant-rated questionnaire to assess sleep quality and quantity. Consists of 9-item overall sleep problems index (length of time to fall asleep, how many hours of sleep each night during past 4 weeks); The MOS Quantity of Sleep subscales rated 0 to 24 (number of hours slept). A higher score indicates greater quantity of sleep. Change = mean scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.17","spread":"0.06"},{"groupId":"OG001","value":"0.46","spread":"0.06"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Medical Outcomes Study (MOS) Sleep Scale at Endpoint- Sleep Adequacy","description":"MOS: participant-rated questionnaire to assess sleep quality and quantity. Consists of 9-item overall sleep problems index (length of time to fall asleep, how many hours of sleep each night during past 4 weeks); The MOS Sleep Adequacy subscales rated 1 (all the time) to 6 (none of the time). Scores are transformed (actual raw score minus lowest possible score) divided by possible raw score range multiplied by 100; total score range = 0 to 100. A higher score indicates greater intensity of sleep adequacy. Change = mean scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.02","spread":"1.41"},{"groupId":"OG001","value":"15.50","spread":"1.40"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Medical Outcomes Study (MOS) Sleep Scale at Endpoint- Somnolence","description":"MOS: participant-rated questionnaire to assess sleep quality and quantity. Consists of 9-item overall sleep problems index (length of time to fall asleep, how many hours of sleep each night during past 4 weeks); The MOS Somnolence subscales rated 1 (all the time) to 6 (none of the time). Scores are transformed (actual raw score minus lowest possible score) divided by possible raw score range multiplied by 100; total score range = 0 to 100. A higher score indicates greater intensity of somnolence. Change = mean scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.66","spread":"1.29"},{"groupId":"OG001","value":"6.65","spread":"1.28"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Medical Outcomes Study (MOS) Sleep Scale at Endpoint- Overall Sleep Problems Index","description":"MOS: participant-rated questionnaire to assess sleep quality and quantity. Consists of 9-item overall sleep problems index (length of time to fall asleep, how many hours of sleep each night during past 4 weeks); The MOS Overall Sleep Problems Index subscales rated 1 (all the time) to 6 (none of the time). Scores are transformed (actual raw score minus lowest possible score) divided by possible raw score range multiplied by 100; total score range = 0 to 100. A higher score indicates greater intensity of overall sleep problems. Change = mean scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.07","spread":"0.96"},{"groupId":"OG001","value":"-10.06","spread":"0.95"}]}]}]},{"type":"SECONDARY","title":"Medical Outcomes Study (MOS) Sleep Scale - Number of Participants With Optimal Sleep at Endpoint","description":"MOS-Sleep is a patient-rated questionnaire to assess sleep quality and quantity. Optimal sleep component is derived from Sleep Quantity average hours of sleep each night during the past 4 weeks. Optimal sleep was defined as sleep quantity of 7 or 8 hours per night.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"53","spread":null},{"groupId":"OG001","value":"71","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Sleep Quality Score at Endpoint","description":"Change: Mean sleep quality score at endpoint minus mean at baseline. Sleep quality scores range from 0-10 with higher scores indicating decreased sleep quality.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.79","spread":"0.12"},{"groupId":"OG001","value":"-1.52","spread":"0.12"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fibromyalgia Impact Questionnaire (FIQ) at Endpoint - Total Scores","description":"FIQ is a 20-item patient-reported outcome instrument designed to assess health status, progress, and outcomes in patients with fibromyalgia (10 subscales; 11 questions). Scores range from 0 to 100 with higher scores indicating more impairment. Change = mean FIQ scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.26","spread":"1.08"},{"groupId":"OG001","value":"-10.59","spread":"1.07"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fibromyalgia Impact Questionnaire (FIQ) at Endpoint - Physical Function","description":"FIQ is a 20-item patient-reported outcome instrument designed to assess health status, progress, and outcomes in patients with fibromyalgia (10 subscales; 11 questions). Scores range from 0 to 100 with higher scores indicating more impairment. Change = mean FIQ scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.19","spread":"0.11"},{"groupId":"OG001","value":"-0.47","spread":"0.11"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fibromyalgia Impact Questionnaire (FIQ) at Endpoint - Feel Good","description":"FIQ is a 20-item patient-reported outcome instrument designed to assess health status, progress, and outcomes in patients with fibromyalgia (10 subscales; 11 questions). Scores range from 0 to 100 with higher scores indicating more impairment. Change = mean FIQ scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.82","spread":"0.17"},{"groupId":"OG001","value":"-1.45","spread":"0.17"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fibromyalgia Impact Questionnaire (FIQ) at Endpoint - Work Miss","description":"FIQ is a 20-item patient-reported outcome instrument designed to assess health status, progress, and outcomes in patients with fibromyalgia (10 subscales; 11 questions). Scores range from 0 to 100 with higher scores indicating more impairment. Change = mean FIQ scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.30","spread":"0.15"},{"groupId":"OG001","value":"-0.31","spread":"0.15"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fibromyalgia Impact Questionnaire (FIQ) at Endpoint - Housework","description":"FIQ is a 20-item patient-reported outcome instrument designed to assess health status, progress, and outcomes in patients with fibromyalgia (10 subscales; 11 questions). Scores range from 0 to 100 with higher scores indicating more impairment. Change = mean FIQ scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.00","spread":"0.15"},{"groupId":"OG001","value":"-1.32","spread":"0.15"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fibromyalgia Impact Questionnaire (FIQ) at Endpoint - Pain","description":"FIQ is a 20-item patient-reported outcome instrument designed to assess health status, progress, and outcomes in patients with fibromyalgia (10 subscales; 11 questions). Scores range from 0 to 100 with higher scores indicating more impairment. Change = mean FIQ scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.06","spread":"0.15"},{"groupId":"OG001","value":"-1.46","spread":"0.15"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fibromyalgia Impact Questionnaire (FIQ) at Endpoint - Tiredness","description":"FIQ is a 20-item patient-reported outcome instrument designed to assess health status, progress, and outcomes in patients with fibromyalgia (10 subscales; 11 questions). Scores range from 0 to 100 with higher scores indicating more impairment. Change = mean FIQ scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.94","spread":"0.14"},{"groupId":"OG001","value":"-1.43","spread":"0.14"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fibromyalgia Impact Questionnaire (FIQ) at Endpoint - Morning","description":"FIQ is a 20-item patient-reported outcome instrument designed to assess health status, progress, and outcomes in patients with fibromyalgia (10 subscales; 11 questions). Scores range from 0 to 100 with higher scores indicating more impairment. Change = mean FIQ scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.97","spread":"0.15"},{"groupId":"OG001","value":"-1.56","spread":"0.15"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fibromyalgia Impact Questionnaire (FIQ) at Endpoint - Stiffness","description":"FIQ is a 20-item patient-reported outcome instrument designed to assess health status, progress, and outcomes in patients with fibromyalgia (10 subscales; 11 questions). Scores range from 0 to 100 with higher scores indicating more impairment. Change = mean FIQ scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.90","spread":"0.15"},{"groupId":"OG001","value":"-1.05","spread":"0.15"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fibromyalgia Impact Questionnaire (FIQ) at Endpoint - Anxious","description":"FIQ is a 20-item patient-reported outcome instrument designed to assess health status, progress, and outcomes in patients with fibromyalgia (10 subscales; 11 questions). Scores range from 0 to 100 with higher scores indicating more impairment. Change = mean FIQ scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.64","spread":"0.16"},{"groupId":"OG001","value":"-0.92","spread":"0.16"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fibromyalgia Impact Questionnaire (FIQ) at Endpoint - Depression","description":"FIQ is a 20-item patient-reported outcome instrument designed to assess health status, progress, and outcomes in patients with fibromyalgia (10 subscales; 11 questions). Scores range from 0 to 100 with higher scores indicating more impairment. Change = mean FIQ scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.51","spread":"0.14"},{"groupId":"OG001","value":"-0.55","spread":"0.14"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Analysis of SF-36 Health Survey Results at Endpoint- Physical Functioning","description":"Subject-rated measure of health status comprised of 36 items: 8 subscale scores (physical functioning, role limitations-physical, bodily pain, general health perceptions, vitality, social functioning, role limitations-emotional, and mental health. Subscale scores range: 0-100. Higher subscale scores = better health status. Change from baseline = score at observation minus score at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.72","spread":"0.93"},{"groupId":"OG001","value":"9.01","spread":"0.93"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Analysis of SF-36 Health Survey Results at Endpoint- Role Limitations-Physical","description":"Subject-rated measure of health status comprised of 36 items: 8 subscale scores (physical functioning, role limitations-physical, bodily pain, general health perceptions, vitality, social functioning, role limitations-emotional, and mental health. Subscale scores range: 0-100. Higher subscale scores = better health status. Change from baseline = score at observation minus score at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.36","spread":"1.30"},{"groupId":"OG001","value":"10.04","spread":"1.30"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Analysis of SF-36 Health Survey Results at Endpoint- Bodily Pain","description":"Subject-rated measure of health status comprised of 36 items: 8 subscale scores (physical functioning, role limitations-physical, bodily pain, general health perceptions, vitality, social functioning, role limitations-emotional, and mental health. Subscale scores range: 0-100. Higher subscale scores = better health status. Change from baseline = score at observation minus score at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.50","spread":"1.06"},{"groupId":"OG001","value":"11.65","spread":"1.06"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Analysis of SF-36 Health Survey Results at Endpoint- General Health Perception","description":"Subject-rated measure of health status comprised of 36 items: 8 subscale scores (physical functioning, role limitations-physical, bodily pain, general health perceptions, vitality, social functioning, role limitations-emotional, and mental health. Subscale scores range: 0-100. Higher subscale scores = better health status. Change from baseline = score at observation minus score at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.83","spread":"0.85"},{"groupId":"OG001","value":"4.66","spread":"0.85"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Analysis of SF-36 Health Survey Results at Endpoint- Social Functioning","description":"Subject-rated measure of health status comprised of 36 items: 8 subscale scores (physical functioning, role limitations-physical, bodily pain, general health perceptions, vitality, social functioning, role limitations-emotional, and mental health. Subscale scores range: 0-100. Higher subscale scores = better health status. Change from baseline = score at observation minus score at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.84","spread":"1.38"},{"groupId":"OG001","value":"8.43","spread":"1.37"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Analysis of SF-36 Health Survey Results at Endpoint- Role Limitations-Emotional","description":"Subject-rated measure of health status comprised of 36 items: 8 subscale scores (physical functioning, role limitations-physical, bodily pain, general health perceptions, vitality, social functioning, role limitations-emotional, and mental health. Subscale scores range: 0-100. Higher subscale scores = better health status. Change from baseline = score at observation minus score at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.50","spread":"1.36"},{"groupId":"OG001","value":"3.27","spread":"1.35"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Analysis of SF-36 Health Survey Results at Endpoint- Vitality","description":"Subject-rated measure of health status comprised of 36 items: 8 subscale scores (physical functioning, role limitations-physical, bodily pain, general health perceptions, vitality, social functioning, role limitations-emotional, and mental health. Subscale scores range: 0-100. Higher subscale scores = better health status. Change from baseline = score at observation minus score at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.12","spread":"1.22"},{"groupId":"OG001","value":"9.53","spread":"1.21"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Analysis of SF-36 Health Survey Results at Endpoint- Mental Health","description":"Subject-rated measure of health status comprised of 36 items: 8 subscale scores (physical functioning, role limitations-physical, bodily pain, general health perceptions, vitality, social functioning, role limitations-emotional, and mental health. Subscale scores range: 0-100. Higher subscale scores = better health status. Change from baseline = score at observation minus score at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.33","spread":"0.98"},{"groupId":"OG001","value":"5.97","spread":"0.98"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Hospital Anxiety and Depression Scale (HADS) - Anxiety","description":"Change: Mean HADS score at observation minus Mean at baseline. HADS anxiety and depression subscale scores range from 0 to 21, with higher scores indicating greater severity of the subscale condition.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.09","spread":"0.18"},{"groupId":"OG001","value":"-0.57","spread":"0.18"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Hospital Anxiety and Depression Scale (HADS) - Depression","description":"Change: Mean HADS score at observation minus Mean at baseline. HADS anxiety and depression subscale scores range from 0 to 21, with higher scores indicating greater severity of the subscale condition.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.00","spread":"0.20"},{"groupId":"OG001","value":"-0.29","spread":"0.20"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Pain Visual Analog Scale (Pain VAS) Score at Endpoint","description":"The pain VAS is a horizontal line; 100 mm in length, self-administered by the patient to rate pain from 0 (no pain) to 100 (worst possible pain). The score indicates the pain intensity during the past 1 week before a visit. Change = mean scores at observation minus mean scores at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.11","spread":"1.45"},{"groupId":"OG001","value":"-20.30","spread":"1.44"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":248},"commonTop":["Somnolence","Nasopharyngitis","Dizziness","Constipation","Weight increased"]}}}